Peripheral Neuropathy
Peripheral neuropathy often caused by diabetes, chemotherapy, or injury , results from impaired nerve cell energy production. Our neuropathy program focuses on restoring mitochondrial function to improve nerve signaling, relieve pain, and support regeneration. Through controlled laboratory studies, the team is identifying metabolic pathways that can be optimized to strengthen nerve performance.
Your contribution sustains research that may potentially lead to non-invasive ways to improve nerve health and energy balance. Funding supports cell-based testing and data analysis required to translate these findings into future applications.
-
Many cancer survivors experience persistent neuropathy after chemotherapy. BioShift is studying approaches to enhance mitochondrial function, the energy source of nerve cells, to help restore signaling and sensation.
-
Despite how common neuropathy is, there are few effective therapies. Current options focus on symptom relief rather than repair.
BioShift’s research aims to identify non-invasive strategies that address the root cause: impaired nerve energy production.
-
By combining metabolic research with clinical insight, BioShift hopes to lay the groundwork for targeted, regenerative solutions that improve quality of life for people living with neuropathy.
